1. Jacoby RM, Nesto RW: Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992, 20(3):736-744.
2. Lejay A, Fang F, John R, Van JA, Barr M, Thaveau F, Chakfe N, Geny B, Scholey JW: Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J Mol Cell Cardiol 2016, 91:11-22.
3. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5):1124-1136.
4. Heusch G, Botker HE, Przyklenk K, Redington A, Yellon D: Remote ischemic conditioning. J Am Coll Cardiol 2015, 65(2):177-195.
5. Schmidt MR, Smerup M, Konstantinov IE, Shimizu M, Li J, Cheung M, White PA, Kristiansen SB, Sorensen K, Dzavik V et al: Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. Am J Physiol Heart Circ Physiol 2007, 292(4):H1883-1890.
6. Yang S, Abbott GW, Gao WD, Liu J, Luo C, Hu Z: Involvement of glycogen synthase kinase-3beta in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats. J Appl Physiol (1985) 2017, 122(5):1095-1105.
7. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S et al: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010, 375(9716):727-734.
8. White SK, Frohlich GM, Sado DM, Maestrini V, Fontana M, Treibel TA, Tehrani S, Flett AS, Meier P, Ariti C et al: Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2015, 8(1 Pt B):178-188.
9. Wider J, Przyklenk K: Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovasc Diagn Ther 2014, 4(5):383-396.
10. Hu Z, Hu S, Yang S, Chen M, Zhang P, Liu J, Abbott GW: Remote Liver Ischemic Preconditioning Protects against Sudden Cardiac Death via an ERK/GSK-3beta-Dependent Mechanism. PLoS One 2016, 11(10):e0165123.
11. Hausenloy DJ, Yellon DM: New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004, 61(3):448-460.
12. Luo N, Liu J, Chen Y, Li H, Hu Z, Abbott GW: Remote ischemic preconditioning STAT3-dependently ameliorates pulmonary ischemia/reperfusion injury. PLoS One 2018, 13(5):e0196186.
13. Yang G, Yang Y, Li Y, Hu Z: Remote liver ischaemic preconditioning protects rat brain against cerebral ischaemia-reperfusion injury by activation of an AKT-dependent pathway. Exp Physiol 2020, 105(5):852-863.
14. Hu Z, Chen M, Zhang P, Liu J, Abbott GW: Remote ischemic preconditioning differentially attenuates post-ischemic cardiac arrhythmia in streptozotocin-induced diabetic versus nondiabetic rats. Cardiovasc Diabetol 2017, 16(1):57.
15. Hu Z, Crump SM, Zhang P, Abbott GW: Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction. Cardiovasc Res 2016, 110(2):227-237.
16. Li H, Liu Z, Wang J, Wong GT, Cheung CW, Zhang L, Chen C, Xia Z, Irwin MG: Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovasc Diabetol 2013, 12:133.
17. Nystrom T, Sartipy U, Franzen S, Eliasson B, Gudbjornsdottir S, Miftaraj M, Lagerqvist B, Svensson AM, Holzmann MJ: PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease. J Am Coll Cardiol 2017, 70(12):1441-1451.
18. Noorbakhsh MF, Arab HA, Kazerani HR: Liver ischemia preconditions the heart against ischemia-reperfusion arrhythmias. Iran J Basic Med Sci 2015, 18(1):80-88.
19. Sivaraman V, Hausenloy DJ, Wynne AM, Yellon DM: Preconditioning the diabetic human myocardium. J Cell Mol Med 2010, 14(6B):1740-1746.
20. Whittington HJ, Harding I, Stephenson CI, Bell R, Hausenloy DJ, Mocanu MM, Yellon DM: Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. Cardiovasc Res 2013, 99(4):694-704.
21. Han Z, Cao J, Song D, Tian L, Chen K, Wang Y, Gao L, Yin Z, Fan Y, Wang C: Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia/reperfusion injury in normal mice, but not diabetic mice. PLoS One 2014, 9(1):e86838.
22. Hausenloy DJ, Tsang A, Yellon DM: The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005, 15(2):69-75.
23. Hu Z, Liu J, Zhou L, Tian X, Abbott GW: AKT and ERK1/2 activation via remote ischemic preconditioning prevents Kcne2-dependent sudden cardiac death. Physiol Rep 2019, 7(3):e13957.
24. Heinen NM, Putz VE, Gorgens JI, Huhn R, Gruber Y, Barthuber C, Preckel B, Pannen BH, Bauer I: Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. Shock 2011, 36(1):45-53.
25. Forde JE, Dale TC: Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 2007, 64(15):1930-1944.
26. Tamareille S, Mateus V, Ghaboura N, Jeanneteau J, Croue A, Henrion D, Furber A, Prunier F: RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol 2011, 106(6):1329-1339.
27. Rose BA, Force T, Wang Y: Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010, 90(4):1507-1546.
28. Yadav HN, Singh M, Sharma PL: Involvement of GSK-3beta in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart. Mol Cell Biochem 2010, 343(1-2):75-81.
29. Bolli R, Stein AB, Guo Y, Wang OL, Rokosh G, Dawn B, Molkentin JD, Sanganalmath SK, Zhu Y, Xuan YT: A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol 2011, 50(4):589-597.
30. Lecour S: Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?J Mol Cell Cardiol 2009, 47(1):32-40.
31. Kleinbongard P, Skyschally A, Gent S, Pesch M, Heusch G: STAT3 as a common signal of ischemic conditioning: a lesson on "rigor and reproducibility" in preclinical studies on cardioprotection. Basic Res Cardiol 2018, 113(1):3.
32. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK: Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 2001, 33(11):1929-1936.
33. Lee JH, Yang SH, Oh JM, Lee MG: Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus. J Pharm Pharmacol 2010, 62(1):1-23.